|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Depreciation and amortization | |||||
| Asset abandonment | |||||
| Non-cash interest (income) expense | |||||
| Non-cash lease expense | |||||
| Stock-based compensation expense | |||||
| Inventory write-down and losses on noncancellable purchase commitments | |||||
| Change in fair value of common stock warrant liabilities | |||||
| Other non-cash (income) expenses, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued and other liabilities | |||||
| Accrued product warranties | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Maturities and purchases of short-term investments, net | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock and common stock warrants, net of issuance costs | |||||
| Payments on notes payable | |||||
| Proceeds from financing arrangements | |||||
| Debt issuance costs | |||||
| Payments on financing obligations | |||||
| Proceeds from stock options exercised | |||||
| Repurchase of shares from employees for income tax withholding purposes | |||||
| Proceeds from contributions to Employee Stock Purchase Plan | |||||
| Proceeds from warrants exercised | |||||
| Other, net | |||||
| Net cash provided by financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Operating leases included in cash used in operating activities | |||||
| Interest | |||||
| Non-cash investing and financing transactions: | |||||
| Common stock warrants issued for the acquisition of intangible assets | |||||
| Purchase of property and equipment included in accounts payable and accrued and other current liabilities | |||||
| Right-of-use finance lease assets obtained in exchange for lease obligations | |||||
| Warrant vested under contracts with customers | |||||
| Adjustment to right-of-use assets from lease modification | |||||
| Transfers between inventory and property and equipment, net | |||||
| Application of deferred revenue to financing obligations | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current | |||||
| Restricted cash, non-current | |||||
Loading...